SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-030833
Filing Date
2012-05-21
Accepted
2012-05-21 11:01:21
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v313092_10q.htm 10-Q 310363
2 EXHIBIT 3.1 v313092_ex3-1.htm EX-3.1 524
3 EXHIBIT 31.1 v313092_ex31-1.htm EX-31.1 9727
4 EXHIBIT 32.1 v313092_ex32-1.htm EX-32.1 4243
5 GRAPHIC ex3-1pg1.jpg GRAPHIC 103546
  Complete submission text file 0001144204-12-030833.txt   2081467

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nwboob-20120331.xml EX-101.INS 157563
7 XBRL TAXONOMY EXTENSION SCHEMA nwboob-20120331.xsd EX-101.SCH 24532
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwboob-20120331_cal.xml EX-101.CAL 46366
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwboob-20120331_def.xml EX-101.DEF 85613
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwboob-20120331_lab.xml EX-101.LAB 202531
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwboob-20120331_pre.xml EX-101.PRE 109766
Mailing Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814
Business Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814 4256083008
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-33393 | Film No.: 12857336
SIC: 2834 Pharmaceutical Preparations